Tandem Diabetes Care has announced that it expects to treble its worldwide customer base to one million people within the next five years, mainly by switching more T1D users to its products but also by expanding with more products for T2D users.
The predicted growth would mean global sales would jump from $700 million (£511 million) now, to $1.5 billion (£1.09 billion) in 2027
To read more CLICK HERE